None of WA’s 10,679 doctors have applied to prescribe medical cannabis since it was legalized in November.
According to the AMA WA, the lack of interest is because doctors do not believe there is evidence to prescribe medical cannabis for anything other than in paediatric epilepsy and MS.
AMA cautious about medicinal cannabis
But the Australian Medical Association of WA said it remained cautious about the use of medicinal cannabis.
AMA WA president Omar Khorshid said it was important rules around the use of medicinal cannabis remained strict, as its efficacy was still being tested.
"The AMA is certainly not supportive of shortcuts, and instead of avoiding all the regulatory steps, we should be investigating cannabis-based products, how good they are, how safe they are, and once that's been done, they should available just like any other drug," he said.
"The AMA is calling for more research on cannabis-based drugs so that we know what's in them, how well they work, and how safe they are, and once that's done, we'll be able to prescribe to prescribe better drugs for patients to manage these conditions."
Ms Neville said there was international research to show cannabinoid-based products were safe and efficient.
The Department of Health said an application was yet to be received from Ms Neville's doctor, and the department had contacted this doctor to provide information and regulatory assistance.
Trivialization of cannabis consumption goes hand in hand with a growing exposure of children and the number of cannabis poisoning cases is steadily increasing. As clinical presentation can be different from what is currently seen in adults, added to the fact that it is not always suspected, diagnosis of cannabis intoxication in children is often delayed or missed. A 16-month-old girl was admitted to the pediatric emergency unit for an important drowsiness combined to moderate fever. After elimination of infectious causes, a toxic origin was considered and biological analyses led to the diagnosis of involuntary acute cannabis intoxication. In conclusion, cannabis intoxication in child has uncommon presentations compared to that seen in adults. In this context, biological analyses have a great importance for a rapid diagnosis and also for the understanding intoxication circumstance. This is of paramount importance because it may lead to consider child protection measures.
These results suggest that marijuana use leads to altered neural functioning during visuospatial working memory after controlling for other prenatal and current drug use. This alteration appears to be compensated for by the recruitment of blood flow in additional brain regions. It is possible that this compensation may not be sufficient in more real-life situations where this type of processing is required and thus deficits may be observed. Awareness of these neural physiological effects of marijuana in youth is critical.
These results, although only briefly presented, extend previously reported effects of prenatal marijuana exposure on neurophysiological processing during executive functioning. These long term effects highlight the importance of optimizing the prenatal environment. The observed negative long term trans-generational effects are avoidable with knowledge transfer, education and a wider appreciation for the harmful consequences of prenatal marijuana exposure.
Despite a documented relationship between cannabis use and suicidality, little is known about psychological vulnerability factors that may increase suicidality among this high-risk group. The Interpersonal-Psychological Theory of Suicide (IPTS; Joiner, 2005) proposes that people are vulnerable to wanting to die by suicide if they experience both perceived burdensomeness and thwarted belongingness. Daily cannabis users may be especially vulnerable to these factors. The current study used moderated mediation to test whether the relation between daily cannabis use status and suicidal ideation (SI) occurred indirectly via higher levels of both perceived burdensomeness and thwarted belongingness among 209 (76.1% female) current cannabis using undergraduates who used cannabis daily (n=39) or less frequently (n=160). The direct effect of cannabis use status on SI was no longer significant after controlling for thwarted belongingness, perceived burdensomeness, and the thwarted belongingness X perceived burdensomeness interaction. Cannabis use status was predictive of greater SI indirectly through perceived burdensomeness only at higher levels of thwarted belongingness. Findings support the utility of the IPTS in regard to SI among daily cannabis users, indicating that difficulties in interpersonal functioning may serve as potential pathways through which daily cannabis use may lead to greater suicide risk.